reference/22048698

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22048698

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	446
issn	1521-0391 1055-0496
issueIdentifier	5
pageRange	438-446
publicationName	The American Journal on Addictions
startingPage	438
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c9844bbdee9205c4154baa99844748d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e0330f0f5f343598845ce4e39dcdb5bd
bibliographicCitation	Saules KK, Schuh LM, Arfken CL, Reed K, Kilbey MM, Schuster CR. Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy. Am J Addict. 2004 Oct;13(5):438–46. doi: 10.1080/10550490490512762. PMID: 15764422.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf004e089123b6543851f889cdca6ddc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fd645e64f343acf169260a372b96635 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa34c5e328e4d7581a46eaa799b02f60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c6dc7dd1bfd94f2f4da726ed2105278 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44e5fa55835a59f3fdaec4972bbf8ed0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a2a4a9b785054c6feb240a6728c9a5a
date	2004-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15764422 https://doi.org/10.1080/10550490490512762
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20552 https://portal.issn.org/resource/ISSN/1521-0391 https://portal.issn.org/resource/ISSN/1055-0496
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Double‐Blind Placebo‐Controlled Trial of Fluoxetine in Smoking Cessation Treatment Including Nicotine Patch and Cognitive‐Behavioral Group Therapy
discusses	http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M0015639 http://id.nlm.nih.gov/mesh/M0008986 http://id.nlm.nih.gov/mesh/M0026372 http://id.nlm.nih.gov/mesh/M0008635 http://id.nlm.nih.gov/mesh/M0143982
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005473Q000627 http://id.nlm.nih.gov/mesh/D014029Q000628 http://id.nlm.nih.gov/mesh/D015928 http://id.nlm.nih.gov/mesh/D011615 http://id.nlm.nih.gov/mesh/D017367Q000627 http://id.nlm.nih.gov/mesh/D016540Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010078Q000008 http://id.nlm.nih.gov/mesh/D000279 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D015430 http://id.nlm.nih.gov/mesh/D005731Q000008 http://id.nlm.nih.gov/mesh/D003865Q000188 http://id.nlm.nih.gov/mesh/D013375Q000188 http://id.nlm.nih.gov/mesh/D005731Q000627 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D010078Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010919
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9331 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7427

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261213 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129178651 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671

Total number of triples: 63.